Main programme

>> Sunday >> Monday >> Tuesday >> Wednesday




Tuesday 03 July 2018

08:30 - 09:30
Session 26: The ageing man
Chairmen
Jackson Kirkman-Brown, United Kingdom
Francesca Vidal, Spain
08:30 - 09:00
Mechanistic basis of ageing effects
John Aitken, Australia
09:00 - 09:30
The ageing male germ cell
Jörg Gromoll, Germany

08:30 - 09:30
Session 27: In vitro post-implantation models
Chairmen
Bjorn Heindryckx, Belgium
Cristina Eguizabal, Spain
08:30 - 09:00
The use of novel imaging to decipher lineage segregation in the early embryo
Nicolas Plachta, Singapore Rep. of
09:00 - 09:30
Self-organization of the human embryo in the absence of maternal tissues
Magdalena Zernicka-Goetz, United Kingdom

08:30 - 09:30
Session 28: Big data in endometriosis – hope or hype?
Chairmen
Pedro Barri, Spain
Krina Zondervan, United Kingdom
08:30 - 09:00
Big data in understanding disease
David Hunter, United Kingdom
09:00 - 09:30
Big data in endometriosis
Stacey Missmer, U.S.A.

08:30 - 09:30
Session 29: ASRM exchange session: Maximizing the chance of pregnancy for every patient: An intention-to-treat analysis
Chairmen
Christos Coutifaris, U.S.A.
Chairman to be announced
08:30 - 09:00
A rational approach to the management of the older and low response patient undergoing ART
Owen Davis, U.S.A.
09:00 - 09:30
Every last baby out of every last egg: Does PGS really improve the chance of pregnancy for every patient?
Richard J. Paulson, U.S.A.

08:30 - 09:30
Session 30: WHO session: WHO and fertility care: Time to engage?
Chairmen
Roy G Farquharson, United Kingdom
Thabo Matsaseng, Switzerland
08:30 - 08:35
Introduction: HRP vision and goals regarding infertility
Speaker to be announced
08:35 - 08:45
WHO priorities in infertility and fertility care
Thabo Matsaseng, Switzerland
08:45 - 08:55
Estimation of prevalence of infertility from cross-section surveys (DHS) using time-to-pregnancy approach: preliminary results of a pilot study
Thabo Matsaseng, Switzerland
08:55 - 09:05
The landscape of IVF in lower and middle income countries
Tendai Chiware, U.S.A.
09:05 - 09:15
Developing ART practice in low and middle income countries
Willem Ombelet, Belgium
09:15 - 09:25
Discussion
09:25 - 09:30
Closing remarks
Speaker to be announced

08:30 - 09:30
Session 31: Nurses/Midwives invited session
Chairmen
Valerie Blanchet De Mouzon, France
Chairman to be announced
08:30 - 09:00
Use of ultrasound at embryo transfer - is it necessary?
Alison McTavish, United Kingdom
09:00 - 09:30
Family planning, knowledge about fertility and lifestyle prior to conception; nurses and midwives as key persons in preconception care
Tanja Tyden, Sweden

08:30 - 09:30
Product theatre

09:30 - 10:00
Coffee break

09:45 - 10:45
Product theatre

10:00 - 11:30
Session 32: Updates in embryo morphokinetics
Chairmen
Leonie Van Den Hoven, The Netherlands
Marcos Meseguer Escriva, Spain
10:00 - 10:15
The effect of oocyte vitrification on subsequent embryo developmental morphokinetics and blastocyst formation: a prospective time-lapse sibling oocyte study
Stefanie De Gheselle, Belgium
10:15 - 10:30
Duration of blastomere movement post first cytokinesis is an effective predictor for the clinical pregnancy after fresh cleaved embryo transfer: in a minimal stimulation program.
Kazuki Ohata, Japan
10:30 - 10:45
Time Lapse assessment of the occurrence and clinical outcome of direct cleavage in a population of 10,529 embryos cultured to the blastocyst stage
Susan Montgomery, United Kingdom
10:45 - 11:00
Is there a relation between embryo early cleavage abnormalities and blastulation or implantation rates? A retrospective time-lapse imaging study
Roussila Naam Ouarezki, France
11:00 - 11:15
Partial embryo compaction: what’s behind? Morphokinetic origins and chromosomal status
Cristina Lagalla, Italy
11:15 - 11:30
Time-lapse and NGS evaluation of human embryos cultured in single medium versus sequential media: a prospective randomized pilot study
Zhihong Yang, U.S.A.

10:00 - 11:30
Session 33: Intrauterine insemination and flushing
Chairmen
Janneke den Hartog, The Netherlands
Roberto Matorras, Spain
10:00 - 10:15
The effect of intra-uterine slow-release insemination (SRI) on the pregnancy rate in women designated for standard intra-uterine insemination (IUI) – A multicentre randomized, controlled trial
Julian Marschalek, Austria
10:15 - 10:30
What is in unexplained subfertility the impact of gonadotropins or clomiphene citrate on endometrial thickness: a secondary analysis of a trial on intrauterine insemination
Monique H. Mochtar, The Netherlands
10:30 - 10:45
A cost-effectiveness analysis of ovarian stimulation with follicle stimulating hormone (FSH) compared with clomiphene citrate (CC) in intra uterine insemination (IUI)
Noor Danhof, The Netherlands
10:45 - 11:00
Is intrauterine insemination with ovarian stimulation associated with higher chances of ongoing pregnancy compared to expectant management in couples with unexplained subfertility?
Rik van Eekelen, The Netherlands
11:00 - 11:15
Tubal flushing with oil- or water-based contrast medium at hysterosalpingography for infertility: 3-year outcome of a randomized clinical trial
Joukje van Rijswijk, The Netherlands
11:15 - 11:30
Does tubal flushing with oil- versus water-based contrast at hysterosalpingography increase the chance of a second child; long term follow-up of the H2Oil RCT.
Nienke van Welie, The Netherlands

10:00 - 11:30
Session 34: Launch of the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS)
Chairmen
Basil C. Tarlatzis, Greece
Antonio Pellicer, Spain
10:00 - 10:20
Building an international PCOS guideline: Initiative, process and translation
Helena Teede, Australia
10:20 - 10:40
International guideline on PCOS: Diagnosis and treatment
Joop Laven, The Netherlands
10:40 - 11:00
Guideline recommendations: Treatment, emotional wellbeing and pregnancy
Terhi Piltonen, Finland
11:00 - 11:30
Panel discussion
Bart C.J.M. Fauser, The Netherlands
Angelica Lindén Hirschberg, Sweden
Joop Laven, The Netherlands
Robert John Norman, Australia
Terhi Piltonen, Finland
Daniela Romualdi, Italy
Juha S. Tapanainen, Finland
Helena Teede, Australia

10:00 - 11:30
Session 35: Genetic causes of male infertility
Chairmen
Christine Wyns, Belgium
Luis Bassas Arnau, Spain
10:00 - 10:15
Analysis of the chromosome territories dynamic in male germ cells and its association to male infertility
Mireia Solé, Spain
10:15 - 10:30
The altered testicular environment in patients with Klinefelter Syndrome
Dorien Van Saen, Belgium
10:30 - 10:45
A heterozygous DNAJB13 mutation induces multiple morphological and structural abnormalities to the sperm flagella (MMSAF) and may be a cause of idiopathic asthenozoospermia
Li Weina, China
10:45 - 11:00
Defective H3K9 demethylation of the male genome and abnormal first mitosis observed in mouse oocytes injected with human round spermatids
Yoshiteru Kai, Japan
11:00 - 11:15
SPANX A/D subfamily plays a key role in nuclear organisation, metabolism and flagellar-motility of human spermatozoa.
Nerea Subiran, Spain
11:15 - 11:30
Copr5is associated with Miwi and modulated the piRNA pathway, a possible mechanism involved in the human teratozoospermia sperm phenotype
Charlene Innocenti, France

10:00 - 11:30
Session 36: IVF laboratory techniques and management
Chairmen
Cecilia Westin, Sweden
Lluc Coll, Spain
10:00 - 10:15
A two-step protocol for oocyte In Vitro Maturation in PCO/PCOS patients increases the yield and quality of usable embryos and results in ongoing pregnancies
Flor Ines Sanchez Ramos, Belgium
10:15 - 10:30
Assisted oocyte activation significantly increases fertilization and pregnancy rates resulting in healthy live births in patients with oocyte activation deficiencies
Davina Bonte, Belgium
10:30 - 10:45
Three babies born after pronuclear transplantation in young women with unexplained infertility and repeated implantation failure of euploid embryos
Pavlo Mazur, Ukraine
10:45 - 11:00
Blastocysts collapse as an embryo marker of low implantation potential a time-lapse study
Romualdo Sciorio, United Kingdom
11:00 - 11:15
The impact of dry incubation on osmolality of media in time-lapse culture dishes
Georgia Carpenter, New Zealand
11:15 - 11:30
Utility of the Vienna consensus on ART Laboratory Performance Indicators for managing multiple IVF laboratories performance
Geoffrey Howard Trew, United Kingdom

10:00 - 11:30
Session 37: Endometriosis and endometrium: clinical research
Chairmen
Petya Andreeva, Bulgaria
Chairman to be announced
10:00 - 10:15
Endometrial scratching by pipelle biopsy in IVF (the PIP study): A pragmatic randomised controlled trial
Sarah Lensen, New Zealand
10:15 - 10:30
The impact of non-cavity distorting intramural fibroids on IVF outcomes: A systematic review and meta- analysis
Mukhri Hamdan, Malaysia
10:30 - 10:45
Supplementation in adolescent girls with endometriosis (SAGE): A double blind, randomized, placebo-controlled trial
James Nodler, U.S.A.
10:45 - 11:00
The Endometriosis Fertility Index (EFI) can be estimated accurately prior to surgical treatment of endometriosis
Carla Tomassetti, Belgium
11:00 - 11:15
The effect of different IVF protocols for women with endometriosis on their IVF outcomes: A Systematic review and Meta-Analysis
Khine Khine Lwin, Malaysia
11:15 - 11:30
Nationwide cohort study of the risk of major adverse cerebrovascular and cardiovascular events in the Asian women with endometriosis
Hsin-Ju Chiang, Taiwan R.O.C.

11:00 - 12:00
Product theatre

11:45 - 13:00
Industry sponsored symposium

11:45 - 12:45
Session 38: European and global ART monitoring
Chairmen
Carlos Calhaz-Jorge, Portugal
Fernando Prados Mondéjar, Spain
11:45 - 12:15
European IVF-monitoring of ART and development of a strategy for vigilance
Christian De Geyter, Switzerland
12:15 - 12:30
ICMART World Report 2014
Geoffrey David Adamson, U.S.A.
12:30 - 12:45
Gender inequality and utilisation of assisted reproductive technology: an international analysis
Georgina Chambers, Australia

11:45 - 12:45
Session 39: New aspects in polycystic ovary syndrome
Chairmen
Daniela Romualdi, Italy
Rafael Bernabeu - Perez, Spain
11:45 - 12:15
First line treatment in PCOS: what to do?
Fulco Van der Veen, The Netherlands
12:15 - 12:45
Does race and ethnicity matter for metabolic risks in PCOS?
Anuja Dokras, U.S.A.

11:45 - 12:45
Session 40: Errors in IVF: Do they occur and how many?
Chairmen
Søren Ziebe, Denmark
Josep Santalo, Spain
11:45 - 12:15
To err is human: even in IVF
Dominique De Ziegler, France
12:15 - 12:45
This is how many errors occur in the IVF lab: a true analysis
Maria Jose De Los Santos, Spain

11:45 - 12:45
Session 41: Focus on blastocyst stage
Chairmen
Roger Sturmey, United Kingdom
Gustavo Tiscornia, Spain
11:45 - 12:00
Predicting blastocyst formation rate using a hierarchical and data mining-based statistical model
Jazmina Yao Serna, Japan
12:00 - 12:15
Blastocyst morphology grading: what is the most important predictor of live birth when accounting for endometrial receptivity? A multicentre analysis of 2477 single blastocyst transfers.
Ashleigh Storr, Australia
12:15 - 12:30
Predicting live birth by combining cleavage- and blastocyst-stage time-lapse variables using a hierarchical and a data mining-based statistical model
Satoshi Kawachiya, Japan
12:30 - 12:45
Day 5 versus Day 6 fresh and frozen blastocyst transfer cycle outcomes: a systematic review and meta-analysis
Astrid Finet, France

11:45 - 12:45
Session 42: Nursing and midwifery
Chairmen
Helen J. Kendrew, United Kingdom
Clara Pardos Torrents, Spain
11:45 - 12:00
Facilitators and barriers affecting help seeking of infertile women in the United States: A systematic review
Morine Cebert, U.S.A.
12:00 - 12:15
A feasibility and acceptability study of a novel self-help coping intervention for recurrent miscarriage
Sarah Bailey, United Kingdom
12:15 - 12:30
A retrospective observational study to compare the success rate of embryo transfer between Doctors and Nurse Practitioners in a nurse-led fertility centre.
Jane Mutch, United Kingdom
12:30 - 12:45
The importance of a genetic link between siblings after oocyte donation
Sara Somers, Belgium

13:00 - 14:00
SIG Reproductive Endocrinology members' meeting

13:00 - 14:00
Lunch break

14:00 - 15:15
Industry sponsored symposium

14:00 - 15:00
Session 43: MHR symposium: First trimester biomarkers of impaired placentation
Chairmen
Chris Barratt, United Kingdom
Chairman to be announced
14:00 - 14:30
Replication of Cytomegalovirus and Zika virus in first-trimester human placentas, mechanisms of viral pathogenesis and host cell defense
Lenore Pereira, U.S.A.
14:30 - 15:00
Cell-free fetal hemoglobin as a biomarker of impaired place
Stefan Hansson, Sweden

14:00 - 17:00
Session 44: Live surgery session
Chairmen
Michelle Nisolle, Belgium
Antoine Watrelot, France

14:00 - 15:00
Session 45: Managing embryo stress in preimplantation development
Chairmen
Rita Vassena, Spain
Stéphane Viville, France
14:00 - 14:30
Nuclear reprogramming and chromatin functions in oocytes and preimplantation embryos
K.E. Latham, U.S.A.
14:30 - 15:00
Mitochondrial stress in preimplantation development and opportunities for treatment
Rebecca Robker, Australia

14:00 - 15:00
Session 46: Patient session: Surrogacy - the patients' perspective
Chairmen
Satu Rautakallio-Hokkanen, Finland
Klaudija Kordic, Croatia
Afroditi Alexopoulou, Greece
14:00 - 14:20
Surrogacy in Portugal - from struggle to accomplishment
Ana Galhardo, Portugal
14:20 - 14:40
Surrogacy and stratified kinship
Amrita Pande, South Africa
14:40 - 15:00
What is it like to be a wombless woman in the age of ART’s? Patients’ perspectives on gestational surrogacy in Finland
Kaisa Kivipuro, Finland

14:00 - 15:00
Session 47: How to increase people's fertility awareness?
Chairmen
Mariana Martins, Portugal
Chairman to be announced
14:00 - 14:30
Development and impact of fertility campaigns
Lone Schmidt, Denmark
14:30 - 15:00
Preconceptional personalised mHealth lifestyle coaching: \rFirst results of a randomized controlled trial in couples undergoing IVF/ICSI treatment
Régine P.M. Steegers-Theunissen, The Netherlands

15:15 - 16:30
Session 48: Effects on testicular development and germ cell differentiation
Chairmen
Stefan Schlatt, Germany
Farners Amargant, Spain
15:15 - 15:30
Exposure to acetaminophen and ibuprofen affects fetal germ cell development in both sexes in rodent and human
Rod Mitchell, United Kingdom
15:30 - 15:45
Acute myeloid leukemia (AML) impaired mouse male fertility by affecting testicular growth factors, premiotic/miotic and posmiotic spermatogenic cell counts
Yulia Michailov, Israel
15:45 - 16:00
CRISPR/cas9 mediated HSD17B3 gene mutation on mouse Leydig cells: Effectivity of CRISPR/cas9 on testosterone synthesis pathway
Nida Karahan, Turkey
16:00 - 16:15
Busulfan distinctly affected Sertoli cell activity in immature mice
Mahmoud Huleihel, Israel
16:15 - 16:30
The nuclear envelope: an unknown actor of human spermiogenesis
Catherine Metzler-Guillemain, France

15:15 - 16:30
Session 49: Premature Ovarian Insufficiency and poor ovarian response
Chairmen
Georgios Lainas, United Kingdom
Carlos Dosouto, Spain
15:15 - 15:30
High resolution array comparative genomic hybridization contribution to uncover genetic etiologies of idiopathic premature insufficiency: a cohort study
Asma Sassi, Belgium
15:30 - 15:45
ACTH-stimulation in women with low functional ovarian reserve (LFOR) confirms adrenal origin of hypo-androgenism
Vitaly Kushnir, U.S.A.
15:45 - 16:00
Are serum LH levels at the initiation of ovarian stimulation associated with oocyte retrieval yield after GnRH agonist triggering?
Biljana Popovic - Todorovic, Belgium
16:00 - 16:15
Luteal phase stimulation compared with conventional follicular phase stimulation in poor ovarian responders: Results of a randomized control trial
Joaquin Llacer, Spain
16:15 - 16:30
Double stimulation in a single menstrual cycle in patients with reduced ovarian reserve: hormonal characteristics, cumulus cell gene expression, embryological and clinical outcome
Bella Martazanova, Russia C.I.S.

15:15 - 16:30
Session 50: Genetic and epigenetic impact of assisted reproductive technologies
Chairmen
Antonio Capalbo, Italy
Nuno Costa-Borges, Spain
15:15 - 15:30
Increased heteroplasmic load of coding mitochondrial DNA variants in tissues from ART children
Filippo Zambelli, Belgium
15:30 - 15:45
Hypomethylation of imprinted genes in term placenta samples conceived by IVF/ICSI is associated with concomitant changes in post-translational histones modifications
Cécile Choux, France
15:45 - 16:00
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
Ron Van Golde, The Netherlands
16:00 - 16:15
Higher gonadotropin dosage and longer ovarian hyperstimulation do not influence aneuploidy rates
Chelsea Canon, U.S.A.
16:15 - 16:30
Correlation between Embryo Ploidy Status and ovarian response after controlled ovarian Stimulation in ART cycles
Srividya Seshadri, United Kingdom

15:15 - 16:30
Session 51: Immunologic and other treatment options in RM/RIF
Chairmen
Bettina Toth, Austria
Montse Barragan, Spain
15:15 - 15:30
Effect of Administration of Intravenous intralipid on implantation rate in women with implantation failure after IVF/ICSI: A randomized controlled trial
Neeta Singh, India
15:30 - 15:45
Recombinant Human Granulocyte - Colony Stimulating Factor (rhG-CSF) in women with unexplained Recurrent Pregnancy Losses (RESPONSE Study): randomised, double-blind, multicentre, placebo controlled trial
Abey Eapen, U.S.A.
15:45 - 16:00
A reduction in uterine Natural Killer (uNK) cell density in response to luteal-phase endometrial scratch (ES) is associated with improved pregnancy outcome
Mariam Lokman, United Kingdom
16:00 - 16:15
Combinatorial use of Endometrial Receptivity Array (ERA) and PGT-A can improve the clinical outcome in cases with previous ART failures
Necati Findikli, Turkey
16:15 - 16:30
Immune therapies for women with history of unsuccessful implantation undergoing IVF/ICSI treatment - A Cochrane collaboration systematic review
Sonia Asif, United Kingdom

15:15 - 16:30
Session 52: Reproductive epidemiology, socio-cultural aspects and health economy
Chairmen
Virginie Rozée, France
Andrea Bernabeu, Spain
15:15 - 15:30
The DOD (Distance Oocytes Donation) strategy: A safe, efficient and “patient friendly” way to overcome lack of egg’s donors in different countries
Federica Moffa, Spain
15:30 - 15:45
You did not turn up… I did not realise I was invited…: Understanding male attitudes towards fertility awareness and poor engagement
Bola Grace, United Kingdom
15:45 - 16:00
Risk of prostate cancer in ICSI treated men
Yahia Al-Jebari, Sweden
16:00 - 16:15
The Canadian Assisted Reproductive Technologies Register (CARTR) Plus database: A validation study
Vanessa Bacal, Canada
16:15 - 16:30
Assisted reproductive technology (ART) treatment and risk of ovarian cancer
Ditte Vassard, Denmark

16:30 - 17:00
Coffee break

17:00 - 18:15
Industry sponsored symposium

17:00 - 18:00
Session 53: Machine learning and artificial intelligence
Chairmen
Nick Raine-Fenning, United Kingdom
Chairman to be announced
17:00 - 17:15
A pre-treatment counselling tool for predicting the cumulative probability of live birth
Neerujah Balachandren, United Kingdom
17:15 - 17:30
Development and validation of an artificial intelligence based algorithm for the selection of an optimal stimulation protocols in IVF patients
Nuria Correa, Spain
17:30 - 17:45
Optimization of prediction models for live birth and miscarriage rate in intrauterine insemination between homologous and frozen donor semen
María José Soriano, Spain
17:45 - 18:00
Comparison of machine learning models for the prediction of live birth following IVF treatment: an analysis of 463,669 cycles from a national database
Ioannis Sfontouris, Greece

17:00 - 18:00
Session 54: Biomarkers for male fertility
Chairmen
Lars Björndahl, Sweden
Anna Blazquez, Spain
17:00 - 17:15
Afamin, a novel human vitamin E-binding glycoprotein, as a marker of male infertility.
Rocio Nunez - Calonge, Spain
17:15 - 17:30
combining RNA-seq and proteomic profiling in cryopreserved human sperm exposed to sublethal stress: new biomarkers for stress-tolerance in sperm
Maryam Hezavehei, Iran
17:30 - 17:45
Attenuation of peroxiredoxin activity induce apoptosis in seminal plasma of men with idiopathic male infertility: striking the chord for evaluation of a novel biomarker
Baidyanath Chakravarty, India
17:45 - 18:00
Seminal plasma cell-free mitochondrial DNA copy number is associated with human semen quality
Yuezhou Chen, China

17:00 - 18:00
Session 55: Female and male fertility preservation
Chairmen
Christiana Antoniadou, Cyprus
Clara Gonzalez Llagostera, Spain
17:00 - 17:15
Freezing ovarian tissue and simultaneously obtaining an average of 8 mature oocytes without ovarian stimulation - is it a reality?
Dmitry Nikiforov, Denmark
17:15 - 17:30
Recovery of ovarian function after chemotherapy for Hodgkin lymphoma is limited by age, not pretreatment ovarian reserve
Richard Anderson, United Kingdom
17:30 - 17:45
Recombinant AMH prevents primordial follicle loss and long term fertility alteration in cyclophosphamide treated mice
Charlotte Sonigo, France
17:45 - 18:00
Organotypic culture of fresh and cryopreserved-thawed human prepubertal and pubertal testis
Joana Portela, The Netherlands

17:00 - 18:00
Session 56: Biology of oocyte and cumulus complex
Chairmen
Signe Altmäe, Spain
Gorka Barrenetxea Ziarrusta, Spain
17:00 - 17:15
Mitochondrial DNA sequence variation in human oocytes by single-cell mtDNA sequencing
Qiao Zeng, China
17:15 - 17:30
Transcriptional profile of tubulin post translational modification (PTM) enzymes throughout human oocyte meiotic progression in vivo and in vitro
Paraskevi Karamtzioti, Spain
17:30 - 17:45
Dual trigger vs. hCG for final oocyte maturation. A prospective randomized controlled, double blinded study: preliminary results
Jigal Haas, Canada
17:45 - 18:00
Anti-Müllerian hormone promotes granulosa cell proliferation in the preantral-to-early antral follicles, but induces granulosa cell apoptosis during the subsequent follicular development, in the primate ovary
Jing Xu, U.S.A.

17:00 - 18:00
Session 57: Approaching the clinic: Stem cells treatments for infertility
Chairmen
Mieke Geens, Belgium
Anna Seriola, Spain
17:00 - 17:15
Autologous mitochondrial transfer as a complementary technique to ICSI to improve oocyte and embryo quality in IVF patients. A Randomized Pilot Study.
Elena Labarta Demur, Spain
17:15 - 17:30
3D Architecture of endometrial glands in relation to stem cell organisation
Dharani Hapangama, United Kingdom
17:30 - 17:45
Human pluripotent stem cell-derived cells expressing functional follicle-stimulating hormone receptor (FSHR) - a tool for functional studies and disease modeling
Karolina Lundin, Finland
17:45 - 18:00
A novel two-step transplantation procedure using adipose tissue-derived stem cells increases follicle survival by boosting angiogenesis in xenografted frozen-thawed human ovarian tissue
Diego D. Manavella I., Belgium

17:45 - 18:45
Product theatre

18:00 - 19:00
Annual general assembly of members